XINT.ST
Xintela AB
Price:  
0.27 
SEK
Volume:  
177,028.00
Sweden | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

XINT.ST Relative Valuation

-430.7%
Upside

As of 2025-11-18, the Relative Valuation of Xintela AB (XINT.ST) is (0.89) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.27 SEK, the upside of Xintela AB based on Relative Valuation is -430.7%.

The range of the Relative Valuation is (0.96) - (1.03) SEK.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 16.5x - 30.1x 20.5x
Forward P/E multiples 26.0x - 27.9x 27.6x
Fair Price (0.96) - (1.03) (0.89)
Upside -457.5% - -483.9% -430.7%
0.27 SEK
Stock Price
(0.89) SEK
Fair Price

XINT.ST Relative Valuation - Historical P/E Data

Date P/E
2025-11-14 -7.27
2025-11-13 -7.13
2025-11-12 -7.37
2025-11-11 -7.10
2025-11-10 -6.99
2025-11-07 -10.30
2025-11-06 -10.55
2025-11-05 -10.19
2025-11-04 -11.06
2025-11-03 -11.79
2025-10-31 -11.36
2025-10-30 -11.41
2025-10-29 -11.30
2025-10-28 -11.38
2025-10-27 -11.33
2025-10-24 -11.41
2025-10-23 -11.33
2025-10-22 -11.41
2025-10-21 -11.28
2025-10-20 -11.52
2025-10-17 -11.03
2025-10-16 -11.63
2025-10-15 -11.95
2025-10-14 -11.92
2025-10-13 -12.71
2025-10-10 -12.87
2025-10-09 -13.14
2025-10-08 -13.30
2025-10-07 -13.28
2025-10-06 -10.92
2025-10-03 -10.60
2025-10-02 -11.09
2025-10-01 -11.09
2025-09-30 -11.09
2025-09-29 -10.90
2025-09-26 -10.46
2025-09-25 -12.46
2025-09-24 -13.22
2025-09-23 -13.20
2025-09-22 -11.79
2025-09-19 -11.87
2025-09-18 -11.63
2025-09-17 -11.06
2025-09-16 -10.68
2025-09-15 -10.44
2025-09-12 -10.55
2025-09-11 -10.55
2025-09-10 -10.71
2025-09-09 -10.52
2025-09-08 -10.36